MRK

Merck News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.60 -0.83% 71.37 19:59:14
Open Price Low Price High Price Close Price Prev Close
71.19 70.89 72.00 71.68 71.97
more quote information »

Recent News

Date Time Source Heading
9/18/202109:05BWMerck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or..
9/17/202122:00DJNPreview -- Barron's
9/17/202108:04DJNMerck Gets CHMP Backing of Keytruda in Triple-Negative..
9/17/202107:15BWMerck Receives Positive EU CHMP Opinion for KEYTRUDA®..
9/15/202117:20SEEKHouse committee approves portion of spending package that..
9/15/202116:23SEEKNarrower drug pricing bill introduced in House by centrist..
9/15/202108:29SEEKOral version of Gilead's remdesivir demonstrates promising..
9/15/202108:17DJNHookipa Working With Merck in Advanced Head and Neck Cancers
9/14/202108:45NNWHypertension: The Silent Killer Making Loud Noise for..
9/09/202116:26SEEKCodexis and Merck extend supply agreement for enzyme used in..
9/08/202106:45BWMerck To Present New Data From Its Broad Oncology Portfolio..
9/07/202106:45BWMerck’s KEYTRUDA® (pembrolizumab) Approved in China in..
9/01/202107:30DJNMerck, Ridgeback Launch Phase 3 Trial of Covid-19..
9/01/202106:45BWMerck and Ridgeback Biotherapeutics Announce Initiation of..
8/31/202116:05BWFDA Approves Updated Indication for Merck’s KEYTRUDA®..
8/26/202106:45BWMerck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals..
8/25/202110:47EDGARInitial Statement of Beneficial Ownership (3)
8/25/202108:00DJNMerck's Vaxneuvance Hits Key Endpoints in Infant Study
8/25/202106:45BWMerck Announces VAXNEUVANCE™ (Pneumococcal 15-valent..
8/23/202111:13SEEKAgilent companion diagnostic expands CE-IVD mark in Europe..
8/20/202116:56EDGARCurrent Report Filing (8-k)
8/20/202116:45BWLeslie A. Brun Resigns from Merck Board of Directors
8/19/202122:14SEEKActing FDA head Woodcock ruled out as permanent nominee -..
8/18/202108:45DJNWerewolf to Study WTX-124 With Merck's Keytruda in Solid..
8/18/202107:44SEEKWerewolf Therapeutics teams up with Merck for..
8/13/202119:00BWFDA Approves Merck’s Hypoxia-Inducible Factor-2 Alpha..
8/13/202118:41PRNCAMerck Canada entreprend des démarches auprès de Santé Canada..
8/13/202118:39PRNCAMerck Canada Initiates Rolling Submission to Health Canada..
8/11/202118:30BWFDA Approves KEYTRUDA® (pembrolizumab) Plus LENVIMA®..
8/10/202107:25DJNMerck: FDA Accepts Two Applications for Expanded Keytruda..
8/10/202106:45BWFDA Accepts Application for Merck’s KEYTRUDA®..
8/10/202106:42BWFDA Grants Priority Review to Merck’s Supplemental Biologics..
8/05/202108:32SEEKMerck’s Keytruda prolonged recurrence-free survival in..
8/05/202108:15DJNMerck: Keytruda Meets Key Endpoint in Stage II Resected..
8/05/202106:45BWMerck’s KEYTRUDA® (pembrolizumab) Significantly Prolonged..
8/03/202108:45NNWCardiovascular Disease Drug Market Offers Compelling..
8/02/202113:26SEEKModerna gains access to Autolus' binder technology for mRNA..
8/02/202112:48SEEKGlaxoSmithKline submits marketing application for MMR..
8/01/202106:36TRMNMerck Q2 Earnings and Revenue Miss Estimates
7/29/202112:30BWMerck Announces Appointment of Cristal N. Downing as Chief..
7/29/202107:26SEEKMerck narrows 2021 revenue guidance; records $600M benefit..
7/29/202107:01EDGARCurrent Report Filing (8-k)
7/29/202106:31SEEKMerck EPS misses by $0.04, beats on revenue
7/29/202106:30BWMerck Announces Second-Quarter 2021 Financial Results
7/28/202108:00SEEKDosing underway in ALX Oncology/Merck's mid-stage ASPEN-04..
7/27/202113:34BWMerck Announces Fourth-Quarter 2021 Dividend
7/27/202107:53SEEKMerck's late-stage KEYNOTE-355 trial met endpoint of overall..
7/27/202107:51DJNMerck's Keytruda Hits Key Endpoint in Metastatic..
7/27/202107:00DJNMerck Gets FDA Expanded OK for Keytruda in Breast Cancer
7/27/202106:48SEEKFDA OKs Merck's Keytruda/Chemotherapy combo in..
See more news about this stock »


Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.